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Abstract
Background: There is little information about influenza disease among the Cambodian population.
To better understand the dynamics of influenza in Cambodia, the Cambodian National Influenza
Center (NIC) was established in August 2006. To continuously monitor influenza activity, a hospital
based sentinel surveillance system for ILI (influenza like illness) with a weekly reporting and
sampling scheme was established in five sites in 2006. In addition, hospital based surveillance of
acute lower respiratory infection (ALRI) cases was established in 2 sites.
Methods: The sentinel sites collect weekly epidemiological data on ILI patients fulfilling the case
definition, and take naso-pharyngeal specimens from a defined number of cases per week. The
samples are tested in the Virology Unit at the Institut Pasteur in Phnom Penh. From each sample
viral RNA was extracted and amplified by a multiplex RT-PCR detecting simultaneously influenza
A and influenza B virus. Influenza A viruses were then subtyped and analyzed by hemagglutination
inhibition assay. Samples collected by the ALRI system were tested with the same approach.
Results: From 2006 to 2008, influenza circulation was observed mainly from June to December,
with a clear seasonal peak in October shown in the data from 2008.
Conclusion:  Influenza activity in Cambodia occurred during the rainy season, from June to
December, and ended before the cool season (extending usually from December to February).
Although Cambodia is a tropical country geographically located in the northern hemisphere,
influenza activity has a southern hemisphere transmission pattern. Together with the antigenic
analysis of the circulating strains, it is now possible to give better influenza vaccination
recommendation for Cambodia.
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Background
Influenza epidemics occur worldwide annually, resulting
in considerable morbidity and causing 250,000 to
500,000 deaths annually worldwide [1]. The epidemiol-
ogy and prevalence of influenza displays a seasonal pat-
tern in temperate regions. Information concerning
seasonality and prevalence is crucial for development of
effective regional and global seasonal influenza preven-
tion strategies as well as pandemic influenza control
measures [2]. Data on the epidemiology of influenza
however, are particularly limited in tropical countries
[2,3]. To better describe the epidemiology, seasonality
and disease burden of influenza as well as to minimize the
impact of this disease, the World Health Organization
(WHO) formed an Influenza Surveillance Network to
detect the emergence and spread of new influenza anti-
genic variants, to use circulating strains characteristics
information to update the formulation of influenza vac-
cine, and to provide as much warning as possible of the
next pandemic. In 1952, WHO established an interna-
tional laboratory-based surveillance network for influ-
enza. The network currently consists of 125 National
Influenza Centre (NIC) laboratories in 95 countries, and
four WHO Collaborating Centers for Reference and
Research on Influenza (WHO CC) [4].
Prior to the emergence of H5N1 related pandemic threat,
influenza data were scarce in Cambodia as laboratory
capacities were also limited. To better understand influ-
enza in Cambodia, the NIC was established within a joint
collaboration between the Center for Diseases Control
Department/Ministry of Health and the Institut Pasteur in
Cambodia (IPC) in August 2006. We summarize in this
report data gathered from the Cambodian NIC which is
based on sampling ILI patients from 5 sentinel outpa-
tients' departments located across the country. Some of
these sites were also selected for their proximity to neigh-
boring countries since movement across the borders may
result in importation of influenza strains. We also report
influenza data during 2007 - 2009 from two hospitals in
which IPC has collaborated with clinicians to determine
bacterial and viral etiologies of inpatients with acute
lower respiratory infections (ALRI).
Methods
Geographic and climatic background
Cambodia is a country in Southeast Asia, bordered by
Thailand, Laos, Vietnam and the Gulf of Thailand. Cam-
bodia covers 181,035 square kilometers and consists of 27
provinces. As a tropical country, the climate has marked
dry and rainy seasons of relatively equal length with aver-
aging temperatures ranging from 24 to 38 degrees Celsius.
The dry season runs generally from November to April
and the rainy season starts in May-June and ends in Octo-
ber-November.
Study sites
The ILI surveillance encompasses 5 outpatients' depart-
ments located in the following provincial or referral hos-
pitals: Takeo (southern Cambodia), Battambang (western
Cambodia), Kampong Cham (central-north Cambodia),
a pediatric hospital in Siem Reap (north-west Cambodia)
and the National Pediatric hospital in Phnom Penh capi-
tal (central Cambodia). Since April 2007, the Institut Pas-
teur in Cambodia (IPC) has also collaborated with Takeo
and Kampong Cham provincial hospitals to study the eti-
ologies of acute lower respiratory infections among hospi-
talized patients. Each sentinel and study site was required
to randomly collect nasopharyngeal swabs of 5 to 10 ILI
patients per week all year long. For the hospital study we
obtained nasopharyngeal samples from all hospitalized
patients admitted to the two hospital sites collaborating
with ALRI study. Swab specimens were immediately intro-
duced into a sterile tube containing virus transport
medium (VTM), kept in liquid nitrogen containers and
transported to the Institut Pasteur in Phnom Penh on a
weekly basis.
Surveillance and case definition
Multiple respiratory viruses, including respiratory syncy-
tial virus, parainfluenza viruses, adenovirus, and rhinovi-
rus, can mimic influenza symptoms [5]. Since the middle
of 2008, the following WHO definition of ILI was used:
person with sudden onset of fever >38°C armpit and
cough or sore throat in the absence of other diagnosis [6].
From 2006 to early 2008, the ILI case definition was iden-
tical except for the fever criteria which was set at ≥ 37.5°C
armpit temperature. For the ALRI study, all patients were
recruited between April 2007 and March 2009. A case for
the under 5 age group was defined as an illness of <10
days duration that consisted of cough or difficult breath-
ing plus tachypnea. For the 5-14 age group, case definition
included the above signs and symptoms plus fever > 38°C
armpit on admission. For the 15 and over age group, a
case was defined as anyone with fever > 38°C armpit on
admission plus tachypnea or chest pain or auscultatory
crackles. Clinical examination of cases was conducted by
hospital clinicians and recorded alongside demographic
information by means of a standard case report form and
chest-X rays were systematically requested.
Laboratory Methods
The collected naso-pharyngeal samples were immediately
frozen at the hospital in liquid nitrogen and the container
was sent on a weekly basis to the IPC's Virology Unit
where specimens were stored at -80°C prior to testing.
Viral RNA was extracted from 140 μL of VTM by using the
QIAamp Viral RNA Isolation Kit (QIAGEN, CA, USA) and
amplified by multiplex reverse transcriptase-polymerase
chain reaction (RT-PCR) detecting simultaneously influ-
enza A virus, influenza B virus, respiratory syncytial virusBMC Infectious Diseases 2009, 9:168 http://www.biomedcentral.com/1471-2334/9/168
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and human metapneumovirus, as previously reported [7].
Influenza A viruses were subsequently subtyped by con-
ventional RT-PCR methods targeting specifically H1, H3,
N1 and N2 genes (protocols available upon request to
authors). The influenza positive specimens were also
inoculated onto MDCK cells as previously described [8].
The influenza strains were analyzed by a hemagglutina-
tion inhibition (HAI) test using a WHO influenza diag-
nostic kit [9]. A representative number of influenza
isolates was sent each year to the WHO Collaborating
Center in Melbourne, Australia, for further analysis
(Table 1).
Statistical analyses
The comparisons between percentages and two means
were tested by Chi2 test and Student's t test respectively. A
p value < 0.05 was considered significant. Proportions,
means and all statistical analyses were performed using
STATA 9.0 (Statacorp., college station, TX, Texas).
Results
The number of influenza strains identified during the
2006-2008 period by both ILI and ALRI systems are
detailed in Table 1 and Figure 1.
ILI surveillance program tested a total of 3,148 samples
during 2006-2008. The average age of the studied popula-
tion was 11.9 years (range, 1 month-76 years) and 50.8%
were male. Of these, 338 (10.7%) tested positive. The
average age of positive patients was 8.7 years (range, 1
month to 76 years) and 180 (53.3%) were male. There
were no differences in age and gender distribution across
the three testing years. However, the influenza-infected
patients were significantly younger than those tested neg-
ative for influenza viruses (8.7 versus 11.9 years; p <
0.001). Overall positive rates varied from 5.8% in 2006,
7.7% in 2007 and 15.3% in 2008.
The average age among the patients included in the ALRI
study was 38.2 years (range: 1 month to 87 years) and
61.8% were male. Of the 1,868 patients admitted with
ALRI during 2007-2008, only 64 (3.4%) tested positive
for influenza virus - 1.4% in 2007 and 3.6% in 2008. The
average age of positive cases was 15.2 years (range, 3
months to 82 years); 28 (51.7%) were male. The patients
with influenza infection were significantly younger than
the other patients recruited in the ALRI study (p < 0.001).
The difference between both ILI and ALRI system for
influenza detection was significant (p < 0.001).
From 2006 to 2008, influenza infections were observed
mainly from June to December (Figure 1). However, some
influenza activity (mainly influenza B, but not exclu-
sively) was also detected in March 2007. During this time
a human case of influenza A/H5N1 infection was also
identified by the NIC in a patient admitted in a reference
hospital of the capital for severe pneumonia. Incidently,
the H5N1 case detected in 2008 was identified during a
fever surveillance study (Wierzba T, personal communica-
tion).
The proportion of influenza virus detected among ILI
specimens from 2006 to early 2009 varies between 0% in
April and May and 50% in October 2008 (Figure 2). Influ-
enza positivity rates varied between the sentinel sites: 40%
in the National Pediatric hospital in Phnom Penh, 9.5%
in Takeo, 20% in Kampong Cham, 16% in Battambang
and 14.5% in a pediatric hospital in Siem Reap. Only 5 to
10% of the ALRI specimens were positive for influenza
virus during the highest transmission season (from Sep-
tember to November) (Figure 3).
The antigenic analysis show that influenza A/H1N1 iso-
lates belonged to the A/New Caledonia/20/99-like group
in 2007 and A/Brisbane/59/2007-like group in 2008. In
2006 and 2007, A/H3N2 strains tested were close to A/
Wisconsin/67/2005-like, but in 2008 the strains drifted to
A/Brisbane/10/2007-like. The influenza B strains were B/
Malaysia/2506/2004-like in 2007 and B/Florida/4/2006-
like in 2008. These data suggest that the influenza strains
circulating in Cambodia from 2007 to 2008 match with
Table 1: Breakdown of influenza positive isolates by type and subtype in 2006 - 2008
Year No. of specimens No. of positives (%) Type Subtype of influenza A WHOCC, Melbourne*
Influenza A
(%)
Influenza B
(%)
H1N1
(%)
H3N2
(%)
H5N1
(%)
H1N1 H3N2 Influenza B
2006 516 30
(5.8)
30
(100)
00 3 0
(100)
0 N/A 26 N/A
2007 1827 104
(5.7)
44
(42.3)
60
(57.7)
14
(31.8)
29
(65.9)
1
(2.3)
19 24 33
2008 2673 259
(9.7)
171
(66)
88
(34)
31
(18.1)
139
(81.3)
1
(0.6)
31 8 6
* Number of specimens sent to the WHO Collaborating Center in Melbourne from 2006 to 2008.BMC Infectious Diseases 2009, 9:168 http://www.biomedcentral.com/1471-2334/9/168
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the strains contained in the influenza vaccine recom-
mended for the southern hemisphere (Table 2). Neverthe-
less, in 2006, only H3N2 viruses were isolated in
Cambodia and these strains belonged to the A/Wisconsin/
67/2005-like group while the seasonal vaccine for the
southern hemisphere contained the A/California/7/2004-
like strain (Table 2).
Discussion
To our knowledge, this is the first report of influenza activ-
ity in Cambodia. It appears that there is a consistent pat-
Monthly distribution of influenza isolates from late 2006 to early 2009 Figure 1
Monthly distribution of influenza isolates from late 2006 to early 2009.
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Monthly proportion of positive influenza samples among ILI specimens tested from late 2006 to early 2009 Figure 2
Monthly proportion of positive influenza samples among ILI specimens tested from late 2006 to early 2009.
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tern of influenza seasonality during these 3 years, with
detection peaking during the rainy season from June to
December. During the hot and dry seasons there was little
to no detection of influenza, apart from an unusual peak
during March 2007, a period where increased influenza
activity was detected at all 5 sentinel sites. This overall pat-
tern contrasts with that of Northern Vietnam, Thailand or
Singapore in which influenza viruses circulate year-round
and appears more similar to that of countries of southern
hemisphere (Australia, New Zealand) [10-13]. The rea-
Monthly proportion of positive influenza samples among ALRI specimens tested from 2007 to early 2009 Figure 3
Monthly proportion of positive influenza samples among ALRI specimens tested from 2007 to early 2009.
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Table 2: Comparison between vaccine strains and circulating influenza strains in Cambodia from 2006 to 2008.
Season A/H1N1 A/H3N2 Influenza B
Vaccine stain Cambodian 
strains
Vaccine strain Cambodian 
strains
Vaccine strain Cambodian 
strains
2006 A/New Caledonia/
20/1999-like
N/A A/California/7/
2004-like
A/Wisconsin/67/
2005-like
B/Malaysia/2506/
2004-like
N/A
2006-2007 A/New Caledonia/
20/1999-like
A/Wisconsin/67/
2005-like
B/Malaysia/2506/
2004-like
2007 A/New Caledonia/
20/1999-like
A/New Caledonia/
20/1999-like
A/Wisconsin/67/
2005-like
A/Wisconsin/67/
2005-like
B/Malaysia/2506/
2004-like
B/Malaysia/2506/
2004-like
2007-2008 A/Solomon Islands/3/
2006-like
A/Wisconsin/67/
2005-like
B/Malaysia/2506/
2004-like
2008 A/Solomon Islands/3/
2006-like
A/Brisbane/59/2007-
like
A/Brisbane/10/
2007-like
A/Brisbane/10/
2007-like
B/Florida/4/2006-
like
B/Florida/4/2006-
like
2008-2009 A/Brisbane/59/2007-
like
A/Brisbane/10/
2007-like
B/Florida/4/2006-
like
Bolded seasons correspond to the southern hemisphere.BMC Infectious Diseases 2009, 9:168 http://www.biomedcentral.com/1471-2334/9/168
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sons for the seasonality of influenza are not clearly known
and are probably the result of a combination of multiple
factors as, for instance, climate conditions, epidemiology
(population's age, density, migration, etc.), host suscepti-
bility and virus characteristics [14]. Others also reported
that influenza seasonality coincides with rainy season [15-
18] and that temperature and humidity play a more
important role than population factors in driving season-
ality of transmission [18,19]. Importantly, the role of
influenza transmission in schools (and subsequently to
households) is probably very limited in Cambodia
because they are closed from July to September [20].
This study provides data useful for accurate recommenda-
tions on influenza vaccination. People living in Cambo-
dia would ideally receive vaccines by April - May in order
to develop protective immunity before the peak season of
transmission.
We were able to also identify severe influenza infections
among hospitalized patients paralleling the same season-
ality as observed within the NIC's ILI surveillance. To our
surprise, few cases were detected among hospitalized
patients with ALRI. We believe that this low frequency of
cases may not be a reflection of the extent of influenza-
related severity, rather that it is explained by the delay in
hospital admission of Cambodian patients presenting
with severe respiratory infections. Indeed, most bacterial
lung infections included in our hospital study were diag-
nosed among patients who attended hospital too late after
the onset of respiratory symptoms for viral detection
(average, 6 days; IPC's unpublished data). It is plausible
that many of these bacterial infections were secondary
infections from an initial influenza disease. Further test-
ing for influenza using serology should be performed
among patients with bacterial respiratory infections dur-
ing the seasonal epidemics to establish this hypothesis. In
addition, the average age of the patients presenting to hos-
pital with ALRI was significantly higher (p < 0.001) than
patients with ILI symptoms since influenza is mainly
found in children, it may explain the rate differences
between both studies. In 2006, few influenza viruses were
detected, as the NIC and its sentinel sites were just estab-
lished in August 2006. In this year, all influenza-positive
isolates belonged to influenza A/H3N2 sub-type which is
consistent with influenza activity reported worldwide by
WHO. Indeed, in 2006, a low influenza activity was
observed and influenza A/H3N2 virus was the predomi-
nant subtype in many European and Asian countries [21].
In 2007, both influenza A subtypes as well as influenza B
viruses co-circulated at comparable level. Among others,
outbreaks of influenza B virus were also reported in 2007
in China, Hungary and in the United States [22]. In 2008,
influenza A and B viruses were co-circulating as well but
influenza A viruses represented two thirds of the strains
detected. Similar general circulation patterns were
observed worldwide in 2008 and, as in Cambodia, H3N2
subtype was responsible for most outbreaks in some Euro-
pean countries or in Japan [23].
Since the establishment of the NIC and the ILI surveil-
lance system, we observed a regular increase in the influ-
enza positivity rates in the samples that were tested. This
could be linked to a higher influenza activity but also to
an improvement of the system from patient recruitment
(with adjustment of the case definition in 2008 for the
fever criteria), to sample collection and transport to test-
ing. Significant differences in the influenza positivity rate
were observed between the sentinel sites. It was expected
that paediatric hospitals will have a higher positive rate
than adult hospitals, but interestingly, comparing the two
paediatric hospitals, the one based in Phnom Penh pro-
duced more influenza-positive samples than the hospital
located in Siem Reap, perhaps emphasizing the important
role of the physician in the successful recruitment of
patients who are likely to have influenza infection.
There are some limitations to the sentinel surveillance
data. Sentinel data cannot be extrapolated precisely to the
rest of the population, as the outpatients clinic serving
sentinel sites were not truly representative. Random selec-
tion of patients is not yet well standardized and depends
on the goodwill of physicians in participating in influenza
surveillance. In addition, ILI consultation rates were not
provided, and data is lacking on the catchment areas of
the sentinel sites. As a result, little inferences can be made
on disease burden or severity in Cambodia in general.
Despite these problems, the system has been useful in
meeting the purposes of influenza surveillance, identify-
ing the predominant circulating strains in the community
and allowing the formulation of guidelines for influenza
vaccine composition for the subsequent year.
Since 2005, a total of eight human cases of influenza A/
H5N1 have been identified in Cambodia [24]. Interest-
ingly, H5N1 human cases (e.g. in March 2007 and
December 2008) were detected while there was evidence
of background human influenza activities. As in other
Asian countries, there is some evidence of endemicity of
avian influenza H5N1 circulation in poultry in Cambodia
[25]. There is little evidence for human-to-human trans-
mission of the H5N1 virus. Additional mutations or re-
assortment events are probably required to permit effi-
cient human-to-human spread which could trigger a pan-
demic [26,27]. Thus, if H5N1 virus infection in humans
occurs during these seasonal epidemics, the risk of re-
assortment increases.
Even though there is little evidence of mild or asympto-
matic H5N1 human infections, the increasing incidenceBMC Infectious Diseases 2009, 9:168 http://www.biomedcentral.com/1471-2334/9/168
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of cases with influenza-like symptoms have been reported
more frequently since 2005 [28]. In most countries, H5N1
testing is usually limited to symptomatic cases with a
recent history of exposure to dead or sick poultry. Thus, if
the H5N1-infected patients deny contact with the usual
animal source of contamination, hospitalization and test-
ing would be unlikely and the symptoms could be mis-
taken for seasonal flu. Others may not seek medical
attention, assuming that the H5N1 infection is mild and
does not require medical attention, leading to exposure of
others. Hence, H5N1 virus detection by NICs should be
systematic.
Conclusion
This study provides the first data regarding influenza
activity in Cambodia, combining influenza-like illness
surveillance and acute lower respiratory infection surveil-
lance. It demonstrates that even though Cambodia is a
tropical country geographically located in the northern
hemisphere, influenza activity has a southern hemisphere
transmission pattern. Together with the antigenic analysis
of the circulating strains, it is now possible to provide bet-
ter recommendations for influenza vaccination in Cam-
bodia. The ILI surveillance system produced a higher
number of seasonal influenza cases than the ALRI surveil-
lance system. This system is therefore more useful for
maximizing detection of seasonal influenza cases to gen-
erate data regarding vaccine composition, and antiviral
susceptibility. Significantly, the parallel circulation of sea-
sonal and avian influenza viruses represents a risk for pan-
demic by re-assortment during human co-infection. This
highlights the importance to reinforce and develop the
influenza surveillance systems (both ILI and ALRI); espe-
cially in countries where H5N1 virus infection has
become endemic in poultry.
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